Detalhe da pesquisa
1.
Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.
Int J Cancer
; 149(2): 403-408, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709428
2.
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.
Br J Cancer
; 124(9): 1533-1539, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674736
3.
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
Invest New Drugs
; 39(1): 182-192, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910338
4.
Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Support Care Cancer
; 29(5): 2305-2317, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190182
5.
Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.
Lancet Oncol
; 20(11): 1544-1555, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563517
6.
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Am J Gastroenterol
; 114(2): 250-257, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30410039
7.
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.
Support Care Cancer
; 23(9): 2649-54, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25680763
8.
Review on invasion of microplastic in our ecosystem and implications.
Sci Prog
; 105(4): 368504221140766, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426552
9.
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients.
Cancer Cell
; 34(5): 775-791.e3, 2018 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423297
10.
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.
J Clin Oncol
; 34(29): 3562-3569, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528724
11.
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies.
Clin Cancer Res
; 15(22): 7061-8, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19903778